The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.
Craig A. Steger
Advertisement
Craig A. Steger is SVP–Life Sciences at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.
Articles by Craig A. Steger
Advertisement
Latest Updated Articles
Advertisement
Advertisement